Matrix Approach Assessment of Cabotegravir Drug-Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling. - Tracey H; Bate ST; Ford S; Patel P; Bloomer J; Patel A; Taskar KS (Pharmaceutics, 2025)